| Application no. and date | 08806741.8 (espacenet) (Federated) (European Patent Register), 20081009 | | Patent/reg. no. and date | DK/EP 2201012, 20140625 | | Publication date | 20100630 | | Priority no. and date | US 979192 P, 20071011, US 47862, 20080425 | | EP pub. no. and date |
EP 2201012 20100630 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST 103060-EP-EPT | | Inventor | LUKE, Richard, William, Arthur, AstraZeneca R & D Alderley
Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
JOHNSON, Paul, David, AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB,
LEACH, Andrew, AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB,
MATUSIAK, Zbigniew, Stanley, AstraZeneca Intellectual Property
AstraZeneca R&D Alderley
Alderley Park/
Macclesfield, Cheshire SK10 4TG, GB,
MORRIS, Jeffrey, James, AstraZeneca Intellectual Property
AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 487/04 (2006.01) | | Title | PYRROLO[2,3-D]PYRIMIDINDERIVATER SOM PROTEINKINASE B-HÆMMERE | | Int. application no. | GB2008050925 | | Int. publication no. | WO2009047563 | | Related patent (certificate) | CA 2024 00047 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
